| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/31/2023 | 25.28% | Raymond James | $51.5 → $49.5 | Maintains | Outperform |
| 10/27/2023 | 13.9% | Morgan Stanley | $55 → $45 | Maintains | Equal-Weight |
| 10/24/2023 | 13.9% | Susquehanna | $55 → $45 | Maintains | Positive |
| 10/10/2023 | 13.9% | B of A Securities | $50 → $45 | Maintains | Underperform |
| 08/18/2023 | 34.14% | Craig-Hallum | $50 → $53 | Maintains | Hold |
| 08/18/2023 | 13.9% | B. Riley Securities | $46 → $45 | Maintains | Neutral |
| 08/18/2023 | 39.21% | Stifel | $62 → $55 | Maintains | Buy |
| 08/18/2023 | 44.27% | JP Morgan | $64 → $57 | Maintains | Overweight |
| 08/18/2023 | 24.02% | UBS | $48 → $49 | Maintains | Neutral |
| 08/18/2023 | 30.35% | Raymond James | $64 → $51.5 | Maintains | Outperform |
| 08/18/2023 | 56.92% | Rosenblatt | $67 → $62 | Upgrades | Neutral → Buy |
| 08/18/2023 | 49.33% | Needham | → $59 | Reiterates | Buy → Buy |
| 07/25/2023 | 51.86% | Susquehanna | $55 → $60 | Maintains | Positive |
| 07/18/2023 | 26.55% | B of A Securities | → $50 | Downgrades | Neutral → Underperform |
| 07/05/2023 | 6.3% | Barclays | $40 → $42 | Downgrades | Equal-Weight → Underweight |
| 06/21/2023 | 69.58% | Rosenblatt | $48 → $67 | Maintains | Neutral |
| 06/13/2023 | 39.21% | Susquehanna | → $55 | Reiterates | Positive → Positive |
| 05/10/2023 | 39.21% | Loop Capital | $78 → $55 | Maintains | Buy |
| 05/10/2023 | 61.98% | Raymond James | $73 → $64 | Maintains | Outperform |
| 05/10/2023 | 39.21% | Morgan Stanley | $60 → $55 | Maintains | Equal-Weight |
| 05/10/2023 | 21.49% | Rosenblatt | → $48 | Reiterates | → Neutral |
| 05/10/2023 | 1.24% | Barclays | $55 → $40 | Downgrades | Overweight → Equal-Weight |
| 05/10/2023 | 49.33% | Needham | → $59 | Reiterates | → Buy |
| 04/25/2023 | 39.21% | Susquehanna | $70 → $55 | Maintains | Positive |
| 04/18/2023 | 1.24% | Northland Capital Markets | $57 → $40 | Maintains | Market Perform |
| 04/17/2023 | 51.86% | JP Morgan | $54 → $60 | Upgrades | Neutral → Overweight |
| 04/06/2023 | 84.76% | Raymond James | $84 → $73 | Maintains | Outperform |
| 04/06/2023 | 51.86% | Morgan Stanley | $66 → $60 | Maintains | Equal-Weight |
| 04/06/2023 | 26.55% | UBS | $59 → $50 | Maintains | Neutral |
| 04/06/2023 | 26.55% | Craig-Hallum | → $50 | Downgrades | Buy → Hold |
| 04/06/2023 | 39.21% | Barclays | $65 → $55 | Maintains | Overweight |
| 04/06/2023 | 49.33% | Needham | $72 → $59 | Maintains | Buy |
| 04/06/2023 | 21.49% | Rosenblatt | $77 → $48 | Downgrades | Buy → Neutral |
| 03/09/2023 | 77.17% | Susquehanna | → $70 | Reiterates | → Positive |
| 02/10/2023 | 77.17% | Susquehanna | $85 → $70 | Maintains | Positive |
| 02/10/2023 | 44.27% | Northland Capital Markets | $65 → $57 | Maintains | Market Perform |
| 02/10/2023 | 64.52% | Barclays | $70 → $65 | Maintains | Overweight |
| 02/10/2023 | 67.05% | B. Riley Securities | $90 → $66 | Downgrades | Buy → Neutral |
| 02/10/2023 | 112.6% | Raymond James | $85 → $84 | Maintains | Outperform |
| 02/10/2023 | 82.23% | Needham | → $72 | Reiterates | → Buy |
| 01/18/2023 | 87.29% | Rosenblatt | $80 → $74 | Maintains | Buy |
| 12/20/2022 | 61.98% | JP Morgan | $83 → $64 | Downgrades | Overweight → Neutral |
| 12/13/2022 | — | UBS | Initiates Coverage On | → Neutral | |
| 12/13/2022 | 67.05% | Morgan Stanley | $75 → $66 | Maintains | Equal-Weight |
| 12/02/2022 | 72.11% | Stifel | → $68 | Initiates Coverage On | → Buy |
| 11/11/2022 | 56.92% | B of A Securities | $84 → $62 | Downgrades | Buy → Neutral |
| 11/09/2022 | 89.83% | Morgan Stanley | $84 → $75 | Maintains | Equal-Weight |
| 11/09/2022 | 64.52% | Northland Capital Markets | $120 → $65 | Downgrades | Outperform → Market Perform |
| 11/09/2022 | 102.48% | Rosenblatt | $125 → $80 | Maintains | Buy |
| 11/09/2022 | 115.14% | Raymond James | $107 → $85 | Maintains | Outperform |
| 11/09/2022 | 82.23% | Needham | $125 → $72 | Maintains | Buy |
| 10/24/2022 | 102.48% | Barclays | $95 → $80 | Maintains | Overweight |
| 10/19/2022 | 170.82% | Raymond James | $114 → $107 | Maintains | Outperform |
| 10/11/2022 | 112.6% | Morgan Stanley | $98 → $84 | Maintains | Equal-Weight |
| 09/06/2022 | 165.76% | B of A Securities | → $105 | Initiates Coverage On | → Buy |
| 08/17/2022 | 148.04% | Morgan Stanley | $94 → $98 | Maintains | Equal-Weight |
| 08/17/2022 | 188.53% | Raymond James | $102 → $114 | Maintains | Outperform |
| 08/04/2022 | 158.16% | Raymond James | $118 → $102 | Maintains | Outperform |
| 07/25/2022 | 140.45% | Barclays | $100 → $95 | Maintains | Overweight |
| 07/14/2022 | 153.1% | JP Morgan | $115 → $100 | Maintains | Overweight |
| 05/05/2022 | 178.41% | Susquehanna | $120 → $110 | Maintains | Positive |
| 05/05/2022 | 198.66% | Raymond James | $114 → $118 | Maintains | Outperform |
| 05/02/2022 | 137.91% | Morgan Stanley | $97 → $94 | Maintains | Equal-Weight |
| 04/25/2022 | 153.1% | Barclays | $105 → $100 | Maintains | Overweight |
| 04/14/2022 | 191.07% | Craig-Hallum | $130 → $115 | Maintains | Buy |
| 03/24/2022 | 216.38% | Rosenblatt | $115 → $125 | Maintains | Buy |
| 03/15/2022 | 188.53% | Raymond James | $99 → $114 | Maintains | Outperform |
| 03/09/2022 | 203.72% | Northland Capital Markets | $110 → $120 | Maintains | Outperform |
| 02/04/2022 | 145.51% | Morgan Stanley | $91 → $97 | Maintains | Equal-Weight |
| 02/04/2022 | 191.07% | Rosenblatt | $105 → $115 | Maintains | Buy |
| 02/04/2022 | 150.57% | Raymond James | $96 → $99 | Maintains | Outperform |
| 01/26/2022 | 178.41% | JP Morgan | → $110 | Upgrades | Neutral → Overweight |
| 01/20/2022 | 178.41% | JP Morgan | $100 → $110 | Maintains | Neutral |
| 12/15/2021 | 203.72% | Susquehanna | $100 → $120 | Maintains | Positive |
| 12/13/2021 | 153.1% | JP Morgan | $95 → $100 | Maintains | Neutral |
| 11/05/2021 | 153.1% | Barclays | $90 → $100 | Maintains | Overweight |
| 11/05/2021 | 130.32% | Morgan Stanley | $81 → $91 | Maintains | Equal-Weight |
| 11/05/2021 | 165.76% | Rosenblatt | $85 → $105 | Upgrades | Neutral → Buy |
| 10/12/2021 | — | Raymond James | Downgrades | Strong Buy → Outperform | |
| 08/19/2021 | 153.1% | Craig-Hallum | $90 → $100 | Maintains | Buy |
| 08/19/2021 | 115.14% | Rosenblatt | $80 → $85 | Maintains | Neutral |
| 08/19/2021 | 142.98% | Raymond James | $85 → $96 | Maintains | Strong Buy |
| 07/19/2021 | 153.1% | Needham | $87 → $100 | Maintains | Buy |
| 06/01/2021 | 117.67% | Goldman Sachs | $104 → $86 | Downgrades | Buy → Neutral |
| 05/18/2021 | 115.14% | Raymond James | $93 → $85 | Maintains | Strong Buy |
| 05/14/2021 | 102.48% | JP Morgan | $118 → $80 | Downgrades | Overweight → Neutral |
| 05/13/2021 | 127.79% | Susquehanna | $120 → $90 | Maintains | Positive |
| 05/13/2021 | 127.79% | Northland Capital Markets | $130 → $90 | Maintains | Outperform |
| 05/13/2021 | 180.94% | B. Riley Securities | $126 → $111 | Maintains | Buy |
| 05/13/2021 | 127.79% | Craig-Hallum | $120 → $90 | Maintains | Buy |
| 05/13/2021 | 117.67% | MKM Partners | $116 → $86 | Maintains | Buy |
| 05/13/2021 | 102.48% | Rosenblatt | $97 → $80 | Maintains | Neutral |
| 05/13/2021 | 105.01% | Morgan Stanley | → $81 | Downgrades | Overweight → Equal-Weight |
| 05/13/2021 | 120.2% | Needham | $123 → $87 | Maintains | Buy |
| 03/26/2021 | 183.47% | Raymond James | → $112 | Upgrades | Outperform → Strong Buy |
| 03/25/2021 | 211.31% | Needham | $120 → $123 | Maintains | Buy |
| 03/18/2021 | 145.51% | Rosenblatt | $105 → $97 | Downgrades | Buy → Neutral |
| 02/03/2021 | 183.47% | Raymond James | $108 → $112 | Maintains | Outperform |
| 02/03/2021 | 203.72% | Needham | $115 → $120 | Maintains | Buy |
| 01/20/2021 | 173.35% | Raymond James | $93 → $108 | Maintains | Outperform |
| 01/20/2021 | 165.76% | Rosenblatt | $100 → $105 | Maintains | Buy |
| 01/20/2021 | 196.13% | Goldman Sachs | $90 → $117 | Upgrades | Neutral → Buy |
| 12/15/2020 | 165.76% | Morgan Stanley | → $105 | Upgrades | Equal-Weight → Overweight |
| 11/03/2020 | 132.85% | Morgan Stanley | $84 → $92 | Maintains | Equal-Weight |
| 11/03/2020 | 153.1% | Rosenblatt | $105 → $100 | Maintains | Buy |
| 10/13/2020 | 165.76% | Rosenblatt | $110 → $105 | Maintains | Buy |
| 09/18/2020 | 127.79% | Raymond James | $98 → $90 | Maintains | Outperform |
| 09/01/2020 | 148.04% | Stifel | $105 → $98 | Maintains | Buy |
| 08/12/2020 | 112.6% | Morgan Stanley | $75 → $84 | Maintains | Equal-Weight |
| 08/12/2020 | 188.53% | MKM Partners | $107 → $114 | Maintains | Buy |
| 08/12/2020 | 178.41% | Rosenblatt | $105 → $110 | Maintains | Buy |
| 07/23/2020 | 178.41% | Loop Capital | → $110 | Initiates Coverage On | → Buy |
| 05/06/2020 | 140.45% | Jefferies | $80 → $95 | Maintains | Buy |
| 05/06/2020 | 150.57% | B. Riley Securities | $96 → $99 | Maintains | Buy |
| 04/24/2020 | 140.45% | Rosenblatt | $100 → $95 | Maintains | Buy |
| 03/19/2020 | 89.83% | Morgan Stanley | $77 → $75 | Maintains | Equal-Weight |
| 02/05/2020 | 158.16% | Goldman Sachs | $77 → $102 | Reiterates | → Buy |
| 02/05/2020 | 153.1% | Rosenblatt | $90 → $100 | Maintains | Buy |
| 02/04/2020 | 132.85% | Raymond James | $88 → $92 | Maintains | Outperform |
| 01/16/2020 | 135.38% | B. Riley Securities | $75 → $93 | Maintains | Buy |
| 01/10/2020 | 122.73% | Raymond James | → $88 | Downgrades | Strong Buy → Outperform |
| 01/09/2020 | 115.14% | UBS | $71 → $85 | Downgrades | Buy → Neutral |
| 01/02/2020 | 130.32% | MKM Partners | $75 → $91 | Reiterates | → Buy |
| 01/02/2020 | 127.79% | Needham | $70 → $90 | Downgrades | Strong Buy → Buy |
| 12/12/2019 | 127.79% | Susquehanna | → $90 | Initiates Coverage On | → Positive |
| 11/11/2019 | 64.52% | Morgan Stanley | $68 → $65 | Downgrades | Overweight → Equal-Weight |
| 08/09/2019 | 64.52% | Barclays | $60 → $65 | Maintains | Overweight |
| 06/06/2019 | 26.55% | Barclays | $60 → $50 | Maintains | Overweight |
| 03/27/2019 | 64.52% | Morgan Stanley | $55 → $65 | Upgrades | Equal-Weight → Overweight |
| 03/22/2019 | 64.52% | JP Morgan | $50 → $65 | Upgrades | Neutral → Overweight |
| 03/14/2019 | 97.42% | Raymond James | $75 → $78 | Maintains | Strong Buy |
| 01/03/2019 | 115.14% | Raymond James | $87 → $85 | Maintains | Strong Buy |
| 12/11/2018 | 120.2% | Raymond James | $88 → $87 | Maintains | Strong Buy |
| 11/14/2018 | 34.14% | UBS | $80 → $53 | Maintains | Buy |
| 11/13/2018 | 39.21% | Morgan Stanley | $66 → $55 | Maintains | Equal-Weight |
| 11/13/2018 | 87.29% | B. Riley Securities | $88 → $74 | Maintains | Buy |
| 11/13/2018 | 26.55% | JP Morgan | $80 → $50 | Downgrades | Overweight → Neutral |
What is the target price for Lumentum Holdings (LITE)?
The latest price target for Lumentum Holdings (NASDAQ: LITE) was reported by Raymond James on October 31, 2023. The analyst firm set a price target for $49.50 expecting LITE to rise to within 12 months (a possible 25.28% upside). 51 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Lumentum Holdings (LITE)?
The latest analyst rating for Lumentum Holdings (NASDAQ: LITE) was provided by Raymond James, and Lumentum Holdings maintained their outperform rating.
When is the next analyst rating going to be posted or updated for Lumentum Holdings (LITE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lumentum Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lumentum Holdings was filed on October 31, 2023 so you should expect the next rating to be made available sometime around October 31, 2024.
Is the Analyst Rating Lumentum Holdings (LITE) correct?
While ratings are subjective and will change, the latest Lumentum Holdings (LITE) rating was a maintained with a price target of $51.50 to $49.50. The current price Lumentum Holdings (LITE) is trading at is $39.51, which is out of the analyst's predicted range.